| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |